Ventricular hypertrophy blocked delayed anesthetic cardioprotection in rats by alteration of iNOS/COX-2 signaling

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Ma, Leilei ^a,b,c   Kong, Feijuan ^b,d   Ge, Hongwei ^e   Liu, Jingquan ^a   Gong, Fangxiao ^a   Xu, Liang ^a   Hu, Bangchuan ^a   Sun, Renhua ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY   (China)

^e PEKING UNIVERSITY SHOUGANG HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOFLURANE; NITRIC OXIDE; NOS2 PROTEIN, RAT; PTGS2 PROTEIN, RAT;

ANIMAL; APOPTOSIS; BIOSYNTHESIS; CHEMICALLY INDUCED; GENETICS; HEMODYNAMICS; HUMAN; HYPERTROPHY, LEFT VENTRICULAR; MALE; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOPHYSIOLOGY; RAT; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASPASE 3; CYCLOOXYGENASE 2; HEMODYNAMICS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; ISOFLURANE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; SIGNAL TRANSDUCTION;

EID: 84945380999     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07071     Document Type: Article

References (30)

1. Hausenloy, D. J. & Yellon, D. M. The second window of preconditioning (SWOP) where are we now? Cardiovasc Drugs Ther 24, 235-254 (2010).
2. Pagel, P. S. & Hudetz, J. A. Delayed Cardioprotection by Inhaled Anesthetics. J Cardiothoracic Vasc Anesth 25, 1125-1140 (2011).
3. Shinmura, K. et al. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ Res 90, 602-608 (2002).
4. Wakeno-Takahashi, M., Otani, H., Nakao, S., Imamura, H. & Shingu, K. Isoflurane induces second window of preconditioning through upregulation of inducible nitric oxide synthase in rat heart. Am J Physiol Heart Circ Physiol 289, H2585-H2591 (2005).
5. Tanaka, K. et al. Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2. Anesthesiology 100, 525-531 (2004).
6. Guo, Y. et al. The COX-2/PGI2 receptor axis plays an obligatory role in mediating the cardioprotection conferred by the late phase of ischemic preconditioning. PLoS One 7, e41178 (2012).
7. Ehring, T. et al. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide. Circulation 90, 1368-1385 (1994).
8. Jalowy, A., Schulz, R., Dorge, H., Behrends, M.&Heusch, G. Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs. J Am Coll Cardiol 32, 1787-1796 (1998).
9. Xie, H. et al. The changes of technetium-99m-labeled annexin-V in delayed anesthetic preconditioning during myocardial ischemia/reperfusion. Mol Biol Rep 41, 131-137 (2013).
10. Tang, X. L., Stein, A. B., Shirk, G. & Bolli, R. Hypercholesterolemia blunts NO donor-induced late preconditioning against myocardial infarction in conscious rabbits. Basic Res Cardiol 99, 395-403 (2004).
11. Tang, X. L. et al. Hypercholesterolemia abrogates late preconditioning via a tetrahydrobiopterin-dependentmechanism in conscious rabbits. Circulation 112, 2149-2156 (2005).
12. Vogt, M., Motz, W., Scheler, S. & Strauer, B. E. Disorders of coronary microcirculation and arrhythmias in systemic arterial hypertension. Am J Cardiol 65, 45G-50G (1990).
13. Rakusan, K. &Wicker, P. Morphometry of the small arteries and arterioles in the rat heart: effects of chronic hypertension and exercise. Cardiovasc Res 24, 278-284 (1990).
14. Prisant, L. M. Hypertensive heart disease. J Clin Hypertens (Greenwich) 7, 231-238 (2005).
15. Yano, T. et al. Hypertensive hypertrophied myocardium is vulnerable to infarction and refractory to erythropoietin-induced protection. Hypertension 57, 110-115 (2011).
16. Dai, W., Simkhovich, B. Z. & Kloner, R. A. Ischemic preconditioning maintains cardioprotection in aging normotensive and spontaneously hypertensive rats. Exp Gerontol 44, 344-349 (2009).
17. Chiari, P. C. et al. Role of endothelial nitric oxide synthase as a trigger and mediator of isoflurane-induced delayed preconditioning in rabbit myocardium. Anesthesiology 103, 74-83 (2005).
18. Chen, C. H., Chuang, J. H., Liu, K. & Chan, J. Y. Nitric oxide triggers delayed anesthetic preconditioning-induced cardiac protection via activation of nuclear factor kappaB and upregulation of inducible nitric oxide synthase. Shock 30, 241-249 (2008).
19. Tonkovic-Capin, M. et al. Delayed cardioprotection by isoflurane: role of K(ATP) channels. Am J Physiol Heart Circ Physiol 283, H61-H68 (2002).
20. Feng, J. et al. Cardiac remodelling hinders activation of cyclooxygenase-2, diminishing protection by delayed pharmacological preconditioning: role of HIF1 alpha and CREB. Cardiovasc Res 78, 98-107 (2008).
21. Labat-Moleur, F. et al. TUNEL apoptotic cell detection in tissue sections: critical evaluation and improvement. J Histochem Cytochem 46, 327-334 (1998).
22. Ding, B. et al. Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure. Circulation 101, 2854-2862 (2000).
23. Kupai, K. et al. Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. Am J Physiol Heart Circ Physiol 297, H1729-1735 (2009).
24. Iliodromitis, E. K. et al. Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuation. Basic Res Cardiol 105, 193-203 (2010).
25. Diamond, J. A. & Phillips, R. A. Hypertensive heart disease. Hypertens Res 28, 191-202 (2005).
26. Perlini, S. et al. Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy. Hypertension 46, 1213-1218 (2005).
27. Zheng, Z. et al. Gender-related difference of sevoflurane postconditioning in isolated rat hearts: focus on phosphatidylinositol-3-kinase/Akt signaling. J Surg Res 170, e3-e9 (2011).
28. Ma, L. L. et al. Hypertrophied myocardium is refractory to sevoflurane-induced protection with alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3b signals. Shock 40, 217-221 (2013).
29. Bell, R. M., Mocanu, M. M. & Yellon, D. M. Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. JMol Cell Cardiol 50, 940-950 (2011).
30. Wang, M. et al. Glucose regulated proteins 78 protects insulinoma cells (NIT-1) from death induced by streptozotocin, cytokines or cytotoxic T lymphocytes. Int J Biochem Cell Biol 39, 2076-2077 (2007).